Author: Jeff Gelski

LYNGBY, DENMARK – Novozymes and Chr. Hansen completed their merger, creating a company called Novonesis with 10,000 employees, a global research and development network and application centers and activities in 30 industries. Annual revenue will be around €3.7 billion ($4 billion USD).Half of Novonesis’ portfolio will focus on enabling healthier lives and producing better foods, according to the company, while the other half will work to reduce chemical use and target climate-neutral practices. Novozymes provided enzymes and microbial technology. Chr. Hansen develops ingredient systems for the food, pet food, nutritional, pharmaceutical and agricultural industries.Novozymes and Chr. Hansen entered into an…